✦ LIBER ✦

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

✍ Scribed by Jacques Tebib, Xavier Mariette, Pierre Bourgeois…

Book ID: 120706871
Publisher: BioMed Central
Year: 2009
Tongue: English
Weight: 152 KB
Volume: 11
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar2740

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dysport® for the treatment of myofascial

Dysport® for the treatment of myofascial back pain: Results from an open-label, Phase II, randomized, multicenter, dose-ranging study

✍ Gerhard H.H. Müller-Schwefe; Michael A. Überall 📂 Article 📅 2011 🏛 Walter de Gruyter GmbH 🌐 English ⚖ 249 KB

Vedolizumab for the treatment of active

Vedolizumab for the treatment of active ulcerative colitis: A randomized controlled phase 2 dose-ranging study

✍ Asit Parikh; Timothy Leach; Tim Wyant; Catherine Scholz; Serap Sankoh; Diane R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

Comparison of cyclosporin A and azathiop

Comparison of cyclosporin A and azathioprine in the treatment of rheumatoid arthritis — Results of a double-blind multicentre study

✍ K. Krüger; M. Schattenkirchner 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 765 KB

The efficacy and safety of rituximab in

The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial

✍ Paul Emery; Roy Fleischmann; Anna Filipowicz-Sosnowska; Joy Schechtman; Leszek S 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

Canakinumab for the treatment of acute f

Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study

✍ Alexander So; Marc De Meulemeester; Andrey Pikhlak; A. Eftal Yücel; Dominik Rich 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB 👁 2 views

Low-dose oral prednisone improves clinic

Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study

✍ Carlomaurizio Montecucco, Monica Todoerti… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 383 KB